The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response
Authors
Keywords
-
Journal
DNA AND CELL BIOLOGY
Volume 41, Issue 1, Pages 25-29
Publisher
Mary Ann Liebert Inc
Online
2021-12-28
DOI
10.1089/dna.2021.0538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Design of Dissolvable Microneedles for Delivery of a Pfs47-Based Malaria Transmission-Blocking Vaccine
- (2021) Lampouguin Yenkoidiok-Douti et al. ACS Biomaterials-Science & Engineering
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
- (2021) Linde Schoenmaker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A network analysis of COVID-19 mRNA vaccine patents
- (2021) Mario Gaviria et al. NATURE BIOTECHNOLOGY
- Microneedles: A New Generation Vaccine Delivery System
- (2021) Ipshita Menon et al. Micromachines
- A global database of COVID-19 vaccinations
- (2021) Edouard Mathieu et al. Nature Human Behaviour
- Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks
- (2021) Jesse O’Shea et al. Vaccines
- Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19
- (2021) Yue Yin et al. ACS Nano
- Count the cost of disability caused by COVID-19
- (2021) Andrew Briggs et al. NATURE
- mRNA vaccines for infectious diseases: principles, delivery and clinical translation
- (2021) Namit Chaudhary et al. NATURE REVIEWS DRUG DISCOVERY
- Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity
- (2021) Cassie Caudill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock
- (2021) Michael Super et al. Nature Biomedical Engineering
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases
- (2020) Lampouguin Yenkoidiok-Douti et al. ACS Biomaterials-Science & Engineering
- Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
- (2020) Eun Kim et al. EBioMedicine
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles
- (2018) Marianna Yanez Arteta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
- (2017) Nadine G Rouphael et al. LANCET
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Microneedle patches for vaccination in developing countries
- (2016) Jaya Arya et al. JOURNAL OF CONTROLLED RELEASE
- In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers
- (2016) Qin Zeng et al. ACS Biomaterials-Science & Engineering
- Long-term stability of influenza vaccine in a dissolving microneedle patch
- (2016) Matthew J. Mistilis et al. Drug Delivery and Translational Research
- In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers
- (2016) Qin Zeng et al. ACS Biomaterials Science & Engineering
- Messenger RNA-based vaccines: progress, challenges, applications
- (2013) Thomas Kramps et al. Wiley Interdisciplinary Reviews-RNA
- Microneedle-mediated vaccine delivery: Harnessing cutaneous immunobiology to improve efficacy
- (2012) Sharifa Al-Zahrani et al. Expert Opinion on Drug Delivery
- Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations
- (2012) Aditya Pattani et al. JOURNAL OF CONTROLLED RELEASE
- Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety
- (2010) Ryan F. Donnelly et al. DRUG DELIVERY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started